Renaissance BioScience Corp., a Vancouver-based leader in bioengineered yeast, announced on December 4, 2025, that the Mexican patent office has granted a patent for its innovative yeast-based platform technology that enables low-cost production and effective delivery of RNA. This is the third patent issued for the company's RNA technology, following earlier grants in China and Australia, with additional jurisdictions pending. The new patent strengthens Renaissance's intellectual property portfolio, which includes issued and pending patents for yeast-based technologies across multiple end-use markets.
The company's most advanced commercial application of this RNA production and delivery system is a suite of RNAi-based biopesticide products that provide precise, targeted pest control. These products offer a strong environmental safety profile compared with broad-spectrum chemical pesticides, while maintaining competitive production costs at scale. Importantly, the technology integrates smoothly into current farming practices and equipment, making it accessible for widespread adoption.
Dr. John Husnik, Renaissance's CSO and Office of the CEO, commented on the new patent: "This patent from the Mexican office confirms the novelty and importance of our yeast-based RNA technology for producing, protecting and delivering next-generation RNA bioactive molecules. In addition to biopesticides, this platform offers exciting opportunities across a wide range of multi-billion-dollar commercial markets."
The patent grant underscores the growing recognition of RNA interference (RNAi) technology as a sustainable alternative to chemical pesticides. By leveraging yeast as a production host, Renaissance can produce RNA at lower costs and with greater stability, addressing key barriers to commercial viability. The company's platform also has potential applications in animal health, food preservation, and environmental remediation, opening new avenues for growth.
Renaissance continues to expand its IP portfolio and advance its RNA technology toward commercialization. The company's yeast-based approach offers a scalable and eco-friendly solution for pest management, aligning with global trends toward reducing chemical inputs in agriculture. As regulatory approvals and patents accumulate, Renaissance is positioning itself as a key player in the bioeconomy.
